GSD3a interview and survey
Endpoint Outcomes are conducting two studies into GSD3 – an interview study and a research survey. The results will help to guide future research and trials. Both projects are sponsored by Ultragenyx Pharmaceutical. Read their fliers about how you can contribute and how to contact Endpoint Outcomes.